Prednisone 5Mg

DRUG3 trials

Sponsors

M.D. Anderson Cancer Center, University of Mostar, Peking University People's Hospital

Conditions

Immunoglobulin G4-Related DiseaseJanus Kinase InhibitorsPreterm BirthProstate Cancer AggressivenessProstate Carcinoma

Phase 2

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

CompletedNCT03263650

M.D. Anderson Cancer CenterProstate Cancer Aggressiveness, Prostate Carcinoma

Start: 2017-10-03End: 2026-06-10Updated: 2026-06-17

The Effect of Low Doses of Prednisone on the Prolongation of Pregnancy in Threatened Preterm Birth

CompletedNCT06103227

University of MostarPreterm Birth

Start: 2023-11-08End: 2024-12-02Updated: 2025-02-19

Unknown Phase

Tofacitinib in the Treatment of IgG4 Related Diseases

CompletedNCT07827469

Peking University People's HospitalImmunoglobulin G4-Related Disease, Janus Kinase Inhibitors

Start: 2023-04-01End: 2026-06-03Updated: 2026-09-18

Related Papers

Early chemo-induced TME alterations as a predictor of response to PD-1 blockade in AVPC: Single-cell data from C3NIRA.

Journal of Clinical Oncology2026-05-27

C3NIRA: Randomized phase II study of carboplatin-cabazitaxel-cetrelimab (anti-PD-1) induction followed by niraparib +/- cetrelimab maintenance in men with aggressive variant prostate cancers (AVPC).

Journal of Clinical Oncology2025-05-281 citations

Randomized phase II study of olaparib (Ola) maintenance following cabazitaxel-carboplatin induction chemotherapy (CabCarb) in men with aggressive variant prostate cancer (AVPC).

Journal of Clinical Oncology2023-02-204 citations